Author

Kathleen Sprouffske

Novartis (Switzerland)ORCID 0000-0001-7081-2598Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew J. AguirreiD· 1 shared Aparna PadhyeiD· 1 shared Clint A. StalneckeriD· 1 shared Eejung KimiD· 1 shared Fan Yi Kong· 1 shared Joao A. Paulo· 1 shared Joseph Douglas ManciasiD· 1 shared Julien DillyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew J. AguirreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 2, 2026

KRASG12C Inhibition Remodels the Non-Small Cell Lung Cancer Surfaceome to Uncover Targetable Vulnerabilities

Aparna Padhye, Kalisa Kang, Fan Yi Kong…·Joseph Douglas Mancias

This study shows that KRASG12C inhibitors alter the surface proteome of lung cancer cells, revealing FOLR1 as a new target when combined with an antibody drug conjugate.

DOI 10.64898/2026.10.01.756013

humanproteomics

𝕏 PostBluesky